An unexpected jump in the Producer Price Index for December underscores the stubborn nature of inflation, with rising wholesale costs threatening to ripple through the economy and sustain higher prices for households.
French biopharma firm Inventiva (ENXTPA:IVA) has delivered a stunning 126% total return to shareholders over the past year, sharply contrasting with losses over a three-year horizon. As the stock experiences short-term pullbacks, analysts debate whether its current €5.23 price reflects future promise or present hype, with a key drug candidate hanging in the balance.
With Spirit Airlines shrinking operations under bankruptcy protection, JetBlue executives confirm detailed contingency plans are ready to deploy, centering on the crucial Fort Lauderdale hub.
A couple earning $380,000 annually faces a classic high-cost dilemma: Should they stretch for a $1.8 million dream home now or wait? With a hefty down payment saved but significant student debt, their debate highlights the tension between future earnings potential and present financial anxiety in today's premium housing markets.
Shares of USA Rare Earth (NASDAQ: USAR) recovered Wednesday following a sharp sell-off, buoyed by an analyst's upgraded price target and reinforced by a recent $3.5 billion capital infusion from public and private sources.
ING Groep's latest financial results reveal a strategic pivot gaining traction, with fee income now accounting for a fifth of total revenue. The bank has upgraded its income guidance for 2026 and 2027, alongside a robust shareholder return policy, prompting analysts to reassess its growth narrative in a challenging European banking landscape.
The United States, in coordination with European allies, has imposed new sanctions on Iran's Interior Minister and other officials, accusing them of orchestrating a violent suppression of nationwide protests. The measures target assets and travel, reflecting a widening international response to Tehran's handling of domestic unrest.
Shares in Canadian aerospace giant Bombardier plunged 9% following former U.S. President Donald Trump's threat to impose 50% tariffs and decertify its aircraft, escalating trade tensions and sparking alarm across the North American aviation industry.
Clinical-stage biopharma Alumis Inc. (ALMS) is gaining significant Wall Street attention after its lead drug candidate, envudeucitinib, successfully met all endpoints in key Phase 3 trials for plaque psoriasis, prompting multiple analyst upgrades and optimistic price targets.
SharpLink Gaming (NASDAQ: SBET) is drawing bullish attention from major Wall Street firms, with multiple analysts reiterating Buy ratings. The company's substantial Ethereum holdings and management's crypto expertise are seen as key drivers, even as price targets adjust to market conditions.
Investment firm Giverny Capital Asset Management detailed its sale of Fiserv shares in its 2025 year-end letter, pointing to market fixation on artificial intelligence and the financial technology giant's steep decline. The move highlights a broader divergence between fundamental performance and current investor sentiment.
OGE Energy Corp. posts a return on equity in line with industry peers, but a deeper dive reveals a reliance on debt that could signal heightened risk for investors in the evolving utilities sector.
CNBC's Jim Cramer highlights Micron Technology as a key beneficiary of the AI boom and ongoing memory chip shortages, with shares soaring nearly 400% in a year on robust data center demand.
Shares of antibody discovery firm AbCellera Biologics (ABCL) present a complex picture for investors, with strong one-year gains overshadowed by steep declines over longer horizons. As the stock trades near $3.86, a significant gap emerges between its market price and some analyst fair value estimates, raising questions about its premium valuation in a challenging biotech market.
Iran has announced plans to designate the armed forces of European Union member states as terrorist organizations, a direct response to the EU's blacklisting of the Islamic Revolutionary Guard Corps. The escalation marks a new low in diplomatic relations and raises fears of further regional instability.
SoFi Technologies smashed Wall Street's Q4 2025 revenue and profit forecasts, sending its shares sharply higher. However, the digital finance leader's shockingly weak sales outlook for the coming quarter has injected significant uncertainty into its growth narrative.
MPWR shares have surged alongside a broader chip rally, buoyed by ASML's results and bullish internal data growth forecasts for 2026. With stellar short and long-term returns, investors now grapple with conflicting valuation models amid high expectations for AI and data center demand.
EQ Resources (ASX:EQR) has seen its share price skyrocket over 120% in a month, fueled by renewed interest in tungsten and strategic project updates. As the market re-evaluates the critical minerals sector, we examine whether the company's current premium is justified or a sign of overheating sentiment.
Hilton Grand Vacations is moving to integrate its recent acquisition of Bluegreen Vacations, a strategic push aimed at achieving cost savings and unlocking cross-selling potential across an expanded resort network. The success of this complex merger is seen as a critical test of HGV's operational prowess and its ability to compete more effectively in the vacation ownership sector.
A bold congressional proposal to cap credit card interest rates at 10% is drawing sharp criticism from Wall Street and raising fundamental questions about the future profitability of card issuers like American Express.
